• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.
    All News #Library
    Biotech

    Harbour BioMed, Otsuka Partner to Advance BCMAxCD3 T-Cell Engager

    PR NEWSWIRE

    Vertex`s Diabetes Therapy Allows 10 Patients to Come Off Insulin

    ENDPNTS

    Biocon concludes a Rs 4,500 crore equity fundraise through QIP

    INDPHARMAPOST

    Tweaked ACIP vaccine agenda raises industry watcher concerns

    FIERCE PHARMA

    Arialys Presents Promising Data for IgG1 Antibody Treatment

    FIERCE BIOTECH

    Roche Combo Lunsumio & Polivy Doubles Remission in LBCL

    PRESS RELEASE

    Candid Moves T-Cell Engagers Into Autoimmune Trials

    BUSINESSWIRE

    FDA Reviewing Opzelura Cream for Kids With Dermatitis

    BUSINESSWIRE

    Sinovac Board Wins Against Advantech/Prime in New York Lawsuit

    BUSINESSWIRE

    NurExone Joins ARMI HealthTech Hub Accelerator, Updates Strategy

    GLOBENEWSWIRE

    CHMP Backs Darzalex for High-Risk Smouldering Myeloma

    GLOBENEWSWIRE

    Aptose and Hanmi`s New Loan Agreement for Tuspetinib in AML

    GLOBENEWSWIRE

    Actuate Shares Phase 2 Pancreatic Cancer Trial Data

    GLOBENEWSWIRE

    Moleculin Announces $5.9 Million Public Offering

    GLOBENEWSWIRE

    EarlyHealth, UWI Launch Study on Caribbean Disorders

    GLOBENEWSWIRE

    PharmAla Files Preliminary Base Shelf Prospectus

    GLOBENEWSWIRE

    Umbrella Labs Launches Retatrutide for Scientific Research

    ACCESSWIRE

    Aptevo Adds APVO455 to CD3 T-Cell Engager Portfolio

    ACCESSWIRE

    Aptevo Therapeutics Closes $8M Offering Under Nasdaq Rules

    ACCESSWIRE

    CHMP Recommends Bio-Thera’s Stelara Biosimilar Usymro

    PR NEWSWIRE

    Lomond Therapeutics: FDA Clears IND Application for LonitoclaX

    PR NEWSWIRE

    Ratio & TerraPower Sign Actinium-225 Supply Agreement

    PR NEWSWIRE

    Promising Results for Diabetes Patients on Mini Med™ 780 G System

    PR NEWSWIRE

    IISc creates metal-based nanozyme to prevent blood clotting

    PHARMABIZ

    Industry ‘disappointed’ as FDA Puts Gene Therapy Chief on Leave

    FIERCE BIOTECH

    US may be Ending Grants for Biotechs With Foreign Investors

    FIERCE BIOTECH

    Lotte Biologics Signs Antibody Manufacturing Contract with Ottimo

    PR NEWSWIRE

    Zealand`s Dual Agonist Tied to 11% Weight Loss in Phase 1b

    FIERCE BIOTECH

    Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle

    REUTERS

    Biovaxys Announces Amended Life Offering

    PR NEWSWIRE

    Brenus Pharma and InSphero Develop 3D Tumor Spheroids Confirming

    BUSINESSWIRE

    Genethon Highlights Atamyo`s Gene Therapy, LGMD Progress

    BUSINESSWIRE

    Phase Genomics Unveils Bundles for Metagenomics Access

    BUSINESSWIRE

    Quantum-Si, DNAnexus, Others to Tackle Proteomics Data

    BUSINESSWIRE

    PharmaJet® and Immuno Cure Partner for Needle-free HIV Vaccine

    BUSINESSWIRE

    Valneva Chooses CliniOps for Post-Marketing Studies in Brazil

    ACCESSWIRE

    CancerVax Nanoparticle Targets Cancer Cells, Spares Others

    GLOBENEWSWIRE

    Annovis` Plan Accepted by NYSE for Listing Compliance

    GLOBENEWSWIRE

    Memo to Present Ph2 BKV Drug Data at Transplant Congress

    GLOBENEWSWIRE

    Cannara Biotech to Host Investor Webcast on June 25th, 2025

    GLOBENEWSWIRE

    Superlab Suisse to Open New Facility at Campus Biotech in Geneva

    GLOBENEWSWIRE

    RyboDyn Joins Lilly Labs to Target Dark Proteome Therapies

    PR NEWSWIRE

    Zemcelpro Gets Positive CHMP Opinion for Blood Cancer Treatment

    PR NEWSWIRE

    Immuno Cure, PharmaJet Team Up on Needle-Free HIV Vaccine

    PR NEWSWIRE

    Miltenyi Biotec, BIRAC Partner to Boost Therapy in India

    EXPRESSPHARMA

    Incyte Announces FDA Approval of Monjuvi for Lymphoma

    BUSINESSWIRE

    Rfk Jr Weighs Review of Vaccines Citing Aluminum Use

    REUTERS

    ICD 2025: Nemluvio® Shows Long-Term Safety, Symptom Relief

    BUSINESSWIRE

    BostonGene to Present AI Drug Tools at Genomics Festival

    BUSINESSWIRE

    IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Begins

    BUSINESSWIRE

    Phare Bio Wins Newsweek’s AI Impact Award

    BUSINESSWIRE

    Objective Biotechnology Launches Automated Microinjection Robot

    BUSINESSWIRE

    Atalanta Therapeutics Announces Leadership Transitions

    BUSINESSWIRE

    Coya Therapeutics to Present at iAccess Alpha Virtual Conference

    BUSINESSWIRE

    Keytruda Nod Highlights CEL-SCI Opportunity in PD-L1– Cancers

    BUSINESSWIRE

    Infinity Bio secures $8M Series A led by Illumina Ventures

    BUSINESSWIRE

    MAIA Biotech and Roche Sign Clinical Supply Agreement for Cancer

    BUSINESSWIRE

    SINOVAC Board of Directors Files Definitive Proxy Materials

    BUSINESSWIRE

    Quince Therapeutics Closes $22M Private Placement

    BUSINESSWIRE

    Satellos Bioscience Reveals Shareholder Meeting Results

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.